Oct 30, 2025 04:16PM
Oct 30, 2025 07:01AM
Oct 23, 2025 06:03AM
Sep 30, 2025 07:01AM
Apr 15, 2025 09:02AM
Feb 27, 2025 07:05AM
Jan 30, 2025 07:32AM NLS Pharmaceutics (NLSP) Announces the Submission of Three Research Abstracts to the 2025 ASCP Annual Meeting
Jan 28, 2025 07:32AM
Dec 11, 2024 07:32AM
Dec 11, 2024 07:30AM
Dec 4, 2024 01:15PM
Dec 3, 2024 07:41AM
Dec 3, 2024 07:40AM
Nov 18, 2024 07:30AM NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
Oct 28, 2024 07:02AM
Oct 28, 2024 07:00AM
Oct 21, 2024 07:03AM
Oct 21, 2024 07:00AM
Oct 15, 2024 07:00AM
Sep 25, 2024 08:04AM
Sep 25, 2024 08:00AM NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split
Jun 28, 2024 09:02AM
Jun 28, 2024 09:00AM
Jun 27, 2024 08:45AM
Jun 27, 2024 08:07AM
Jun 27, 2024 08:00AM
Jun 27, 2024 08:00AM
Jun 27, 2024 08:00AM NLS Pharmaceutics Announces Promising Preclinical Results for Parkinson's Disease Treatments
Jun 25, 2024 09:13AM
Jun 25, 2024 08:30AM
Jun 11, 2024 08:32AM
Jun 11, 2024 08:30AM

401,534 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All